Thermo Fisher Scientific last week announced the election of William Parrett to its board.
Parrett has been appointed to the company’s audit committee.
Until his retirement last year, Parrett was at Deloitte Touche Tohmatsu for more than 40 years, most recently as global CEO.
Cell BioSciences this week announced Jason Novi has joined the company as its CFO. Also, Robert Gavin was named vice president, engineering, and Wilhelm Lachnit was named vice president, R&D.
Novi will be responsible for the finance, manufacturing, and administrative functions of the firm. Prior to Cell BioSciences, he was vice president of finance at Nektar Therapeutics
. Between 2000 and 2007, he was director of finance at Molecular Devices
Gavin was most recently director of engineering at MDS Analytical Technologies. Lachnit had most recently been at Molecular Devices where he held both scientific and commercial leadership positions.
Cell BioSciences is a startup nanofluidic systems firm. Last month it named Tim Harkness its president and CEO.